In Situ is a technology-based healthcare startup that uses a 3D bioprinting technique to produce biocuratives that contain human cells.
Our main goal is that these biocuratives will in future be used to treat approximately 5 million Brazilians who suffer from chronic wounds and severe skin burns. However, by working with innovative and disruptive health technologies, we have some extra challenges.